Title
Vasopressin and Methylprednisolone vs Placebo and Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest
Date Issued
01 February 2022
Access level
metadata only access
Resource Type
letter
Author(s)
Publisher(s)
American Medical Association
Start page
487
Volume
327
Issue
5
Language
English
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular
Scopus EID
2-s2.0-85123967866
PubMed ID
Source
JAMA - Journal of the American Medical Association
ISSN of the container
00987484
Sponsor(s)
Funding text 1
Funding/Support: The CDL RSC was founded with financial support from 12 corporations: Air Canada, CPP Investments, Genpact, Loblaw Companies Limited, Magna, MDA, Maple Leafs Sports & Entertainment Partnership, Nutrien, Rogers, Scotiabank, Shoppers Drug Mart, and Suncor and received funding from the Safe Restart Agreement from the Government of Canada (Health Canada).
Funding text 2
Conflict of Interest Disclosures: Dr Andersen reported receiving grants from the Aarhus University Research Foundation, the Department of Clinical Medicine at Aarhus University, and Independent Research Fund Denmark and nonfinancial support from Amomed Pharma GmbH, which provided trial drug during the conduct of the study. Dr Granfeldt reported receiving personal fees from Noorik Biopharmaceuticals.
Sources of information:
Directorio de Producción Científica
Scopus